Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study - Top-Institutions - MDSpire

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

  • By

  • Aidana Rakhmankulova

  • Yesbolat Sakko

  • Abduzhappar Gaipov

  • Kuralay Atageldiyeva

  • Talshyn Ukybassova

  • Assem Suleimenova

  • Yerbolat Iztleuov

  • Gulzhanat Aimagambetova

  • June 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Kazakh Research Institute of Oncology and Radiology
    Kazakh Research Institute of Oncology and Radiology

    Almaty, Kazakhstan

    Key Differentiators

    • Oncology
    • Radiology

  • #2

    Nazarbayev University School of Medicine and University Medical Center Corporate Fund
    Nazarbayev University School of Medicine and University Medical Center Corporate Fund

    Astana, Kazakhstan

    Key Differentiators

    • Oncology
    • Gynecologic Oncology

  • #3

    University of Nebraska Medical Center
    University of Nebraska Medical Center

    Omaha, Nebraska

    Key Differentiators

    • Oncology

  • #4

    University Hospital Center in Tirana
    University Hospital Center in Tirana

    Tirana, Albania

    Key Differentiators

    • Oncology

  • #5

    National Oncology Service
    National Oncology Service

    Tirana, Albania

    Key Differentiators

    • Oncology

Original Source(s)

Epidemiology, outcomes of treatment, and survival of cervical cancer in Kazakhstan: a nationwide population-based study

  • by Aidana Rakhmankulova, Yesbolat Sakko, Abduzhappar Gaipov, Kuralay Atageldiyeva, Talshyn Ukybassova, Assem Suleimenova, Yerbolat Iztleuov, Gulzhanat Aimagambetova

  • June 5, 2026

Related Content

Editorial: Autoantibodies in cancer: diagnostic, prognostic, and therapeutic potential

Lobectomy versus sublobar resection for stage I non-small cell lung cancer: an umbrella review of evidence quality, overlap, surgical-extent heterogeneity, and survival outcomes

Integrative oncology: evolution, framework, and future directions